This week the US Food and Drug Administration approved the release of fingolimod (trade name Gilenya®), the first oral medication for the treatment of remitting relapsing multiple sclerosis. Swedish Neuroscience Institute is proud to have participated in the pivotal clinical trial that led to the approval of Gilenya. Gilenya is a welcome addition to the set of medications available to patients living with MS. There are currently five injectable therapies and two intravenous therapies approved by the FDA for the treatment of MS. Although these treatments are very effective, many patients have been hoping for an oral alternative. Some patients are finding that they have “injection fatigue” or are running out of places to inject the medication. It is important to note, however, that not all patients should switch to Gilenya. Patients with stable disease should remain on their medications. Patients need to be informed of the risks associated with Gilenya, including slowed heart rate, increased blood pressure, difficulty breathing, abnormal liver function, and infection, and how these risks may apply to them. If you are wondering whether Gilenya is right for you, please ask your neurologist.
In my first video I talk about why I am doing this and what I hope the outcome will be. Please comment.
Most Recent Articles
Increased dietary fiber and limited sugar and red meat can significantly support good gut health.
Learn what Swedish is doing to improve access and availability to cervical cancer screenings and other essential health care for the LGBTQIA+ community.
The innovative new Women’s Brain Health Program at the Swedish Neuroscience Institute offers women care that can help them get ahead of cognitive decline.
Learn about the many roles social work plays in improving the health of the communities they serve.
A Swedish expert on preventing and treating back injuries.
Two experts at Swedish discuss care disparities experienced by the LGBTQIA+ community and offer their insights about possible solutions.
Swedish’s MS Center is the most comprehensive and among the largest in the United States.
A psychiatrist at Swedish Medical Center talks about alcohol consumption, mindful drinking and making informed choices about your health.
Many people suffer with this painful condition for years before it's treated.
For National Nutrition Month, we’re sharing tips for making small changes, nutrition trends, and ways to help your health and the Earth at the same time.
Now is the time to get back on track with your health and wellness. Your annual exam is a great starting point.
Good health habits, including regular exercise, proper nutrition and proactive health care, play key roles in our ability to stay at home as we age.
Colorectal cancer is one of the deadliest cancers in the United States but also one of the most preventable. Learn how a colonoscopy could save your life.
As part of an international data-sharing consortium of leading cancer centers, Swedish Cancer Institute and Providence Cancer Institute work together to provide genomic data to Project GENIE.
Providence Swedish Chief Health Equity Officer Nwando Anyaoku, M.D., MPH, MBA, recently gave a powerful TEDx talk about the importance of equity and diversity in health care.
A Swedish behavioral health expert explains how becoming more intentional with how we spend our time can be a pathway to finding more joy in our everyday lives.
Menopause is often misunderstood, leading to unnecessary anxiety. Learn the truth about some common myths surrounding perimenopause and menopause.
A cardiologist at Swedish Heart and Vascular Institute discusses cardiac events, the importance of CPR and where to get life-saving training.
An interview with UChicago Medicine Chief of Trauma and Acute Care Surgery Selwyn Rogers, M.D., MPH, who helped launch the collaborative program to train surgical residents.
Cases of the gastrointestinal virus are on the rise. A Swedish infection control expert offers advice for protecting ourselves.